Royal Bank of Canada’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,358
Closed -$4K 7396
2023
Q1
$4K Sell
2,358
-3,494
-60% -$5.93K ﹤0.01% 6270
2022
Q4
$6K Buy
5,852
+5,339
+1,041% +$5.47K ﹤0.01% 6237
2022
Q3
$1K Buy
513
+276
+116% +$538 ﹤0.01% 6865
2022
Q2
$1K Sell
237
-2,088
-90% -$8.81K ﹤0.01% 6808
2022
Q1
$16K Sell
2,325
-4,540
-66% -$31.2K ﹤0.01% 6252
2021
Q4
$58K Buy
6,865
+2,332
+51% +$19.7K ﹤0.01% 5766
2021
Q3
$34K Buy
4,533
+1,975
+77% +$14.8K ﹤0.01% 5869
2021
Q2
$17K Buy
2,558
+275
+12% +$1.83K ﹤0.01% 6156
2021
Q1
$23K Buy
2,283
+1,304
+133% +$13.1K ﹤0.01% 5852
2020
Q4
$7K Buy
979
+679
+226% +$4.86K ﹤0.01% 6001
2020
Q3
$2K Hold
300
﹤0.01% 5860
2020
Q2
$2K Sell
300
-1,849
-86% -$12.3K ﹤0.01% 5857
2020
Q1
$10K Buy
2,149
+805
+60% +$3.75K ﹤0.01% 5342
2019
Q4
$12K Buy
1,344
+1,044
+348% +$9.32K ﹤0.01% 5484
2019
Q3
$1K Hold
300
﹤0.01% 5884
2019
Q2
$1K Hold
300
﹤0.01% 5787
2019
Q1
$2K Hold
300
﹤0.01% 5548
2018
Q4
$1K Sell
300
-316
-51% -$1.05K ﹤0.01% 5710
2018
Q3
$4K Sell
616
-205
-25% -$1.33K ﹤0.01% 5752
2018
Q2
$6K Sell
821
-979
-54% -$7.16K ﹤0.01% 5421
2018
Q1
$40K Buy
1,800
+1,453
+419% +$32.3K ﹤0.01% 4554
2017
Q4
$5K Sell
347
-990
-74% -$14.3K ﹤0.01% 5329
2017
Q3
$21K Buy
1,337
+1,257
+1,571% +$19.7K ﹤0.01% 5185
2017
Q2
$1K Sell
80
-320
-80% -$4K ﹤0.01% 5700
2017
Q1
$9K Buy
+400
New +$9K ﹤0.01% 5341